News for Brickell Biotech, Inc. (BBI)

Published at

Aug 7, 2024 7:00 PM

by globenewswire.com

mixed

mixed

EGFR Inhibitors-Induced Skin Disorders Market to Observe Impressive Growth During the Study Period (2020–2034) | DelveInsight

The EGFR inhibitors-induced skin disorders market has a critical unmet need for approved therapies specific to EGFR inhibitor-induced skin disorders. The...

JAPAY JAPAF 2914.T TKPHF TAKP34.SA TAKN.MX TAK SUNPHARMA-BL.NS BBI 4502.T 4502.S 0A87.L ROGN.MX ROG.SW RO.SW RHHVF RHHBY RHHBF NVSN.MX NVSEF NVSD.BA NVS NOVN.SW N1VS34.SA LLY.MX LLY.DE LLY.BA LLY LILY34.SA JNJ INCY I1NC34.SA GILDD.BA DJNJ3.BA DJNJ2.BA BPMC 0TDF.L 0QQ6.L 0Q1G.L 0K9E.L 0J9P.L 0HOJ.L

Read more →
Published at

Jul 2, 2024 7:00 PM

by globenewswire.com

mixed

mixed

Atopic Dermatitis Market to Register Incremental Growth by 2034, Examines DelveInsight | Key Companies - Arcutis Biotherapeutics, Amgen, Kyowa Kirin, Dermavant Sciences, Cara Therapeutics, Pfizer, Are

The dynamics of the atopic dermatitis market are anticipated to change in the coming years owing to the expected launch of emerging therapies. The rising...

PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE LLY.MX LLY.DE LLY.BA LLY LILY34.SA JAPAY JAPAF IDP.DE GIS.DE GILDD.BA GILD.MX GILD ESALY ESALF DSNKY DSKYF CRVS BIIBD.BA BIIBCL.SN BIIB.SN BIIB.MX BIIB.BA BIIB AMGN.MX AMGN.BA AMGN AMG.DE ALPMY ALPMF ALLK ALDX 4568.T 4523.T 4503N.MX 2914.T 0Q1G.L ZEG.DE VTRSV VTRS.MX VTRS VIA.DE SUNPHARMA.NS SUNPHARMA-BL.NS NVSN.MX NVSEF NVSD.BA NVS NOVN.SW N1VS34.SA GSK.L GSK GS7.DE GLAXF BHCN.MX BHC.TO BHC BBI AZNN.MX AZNCF AZN.L AZN APH.L ABBV34.SA ABBV.MX ABBV.BA ABBV 4AB.DE 0K9E.L 0A4J.L TKPHF TAKP34.SA TAKN.MX TAK ROGN.MX ROG.SW RO.SW RHHVF RHHBY RHHBF MRKD.BA MRK.SN MRK.PA MRK.MX MRK JNJ INCY I1NC34.SA DJNJ3.BA DJNJ2.BA 6MK.DE 4502.T 4502.S 0TDF.L 0QQ6.L 0J9P.L 0A87.L

Read more →
Published at

May 31, 2024 11:32 PM

by investing.com

positive

positive

Exploration capital buys fresh tracks therapeutics shares worth $9,579 By Investing.com

Exploration capital buys fresh tracks therapeutics shares worth $9,579

BBI

Read more →
Published at

Mar 14, 2024 7:09 AM

by gurufocus.com

positive

positive

Brickell Biotech Inc and Voronoi Inc License Agreement Call Transcript

Sep 01, 2021 / 12:30PM GMTOperator Greetings. Welcome to Brickell Biotech Corporate Update Call. (Operator Instructions) Please note that this conference is bei

BBI

Read more →
Published at

Dec 21, 2023 7:00 PM

by globenewswire.com

mixed

mixed

Autoimmune Diseases Diagnostics Global Market to Surpass 6 Billion Mark by 2028 | DelveInsight

The increasing prevalence of autoimmune disorders, including conditions like Rheumatoid Arthritis, Type I Diabetes, and Addison's Disease, is a key driver...

SUNPHARMA.NS CPHRF CPH.TO 039200.KQ XGN SUNPHARMA-BL.NS MYMD LLY.MX LLY.DE LLY.BA LLY LILY34.SA GXE.DE GRFS GRFPN.MX GRF.MC GLPGF GLPG.AS GLPG GILDD.BA GIKLY GIFOF GIFLF BBI ABTCL.SN ABT.SN ABT 0Q1G.L 003520.KS LH.MX LH L1CA34.SA HMGN DSRLF DIA.MI ABCZF ABCM ABC.L 0JSY.L

Read more →
Published at

Oct 10, 2023 7:00 PM

by globenewswire.com

mixed

mixed

Musculoskeletal Pain Market Set to Observe Remunerative Growth During the Study Period (2019-2032) | DelveInsight

The emergence of new products in the pipeline will add to the musculoskeletal pain market growth in the future. In addition, persistently rising cases of...

CPHRF CPH.TO 039200.KQ MYMD GXE.DE GLPGF GLPG.AS GLPG GILDD.BA BBI 4548.T 003520.KS SUNPHARMA-BL.NS LLY.MX LLY.DE LLY.BA LLY LILY34.SA 0Q1G.L

Read more →
Published at

Sep 21, 2023 7:00 PM

by globenewswire.com

mixed

mixed

Sjogren's Syndrome Market Size Increase with Significant CAGR by 2032, Predicts DelveInsight | Key Companies in the Market - Resolve, MorphoSys, Novartis, GlaxoSmithKline, Roche, BMS, TearSolutions, I

Sjogren's syndrome market dynamics are anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, rising awareness...

LLY.MX LLY.DE LLY.BA LLY LILY34.SA INCY I1NC34.SA GXE.DE GLPGF GLPG.AS GLPG GILDD.BA CPHRF CPH.TO 0Q1G.L 0J9P.L 039200.KQ NKTR MYMD BIOCON.NS BIOCON.BO BBI 0UNL.L 003520.KS

Read more →
Published at

Jul 6, 2023 7:00 PM

by globenewswire.com

mixed

mixed

Anti-Inflammatory Drugs Global Market to Accelerate at a CAGR of ~6% by 2028 | DelveInsight

The growing frequency of chronic diseases such as asthma, arthritis, chronic obstructive pulmonary disease (COPD), and others is driving up demand for...

UCBJY UCBJF SUNPHARMA-BL.NS SNCPF PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE NVSN.MX NVSEF NVSD.BA NVS NOVN.SW N1VS34.SA JNJ GLAXF DJNJ3.BA DJNJ2.BA CPHRF CPH.TO AMGN.MX AMGN.BA AMGN AMG.DE 600276.SS 0K9E.L 039200.KQ STAR.NS STAR.BO SNNAQ SILO RKT.L RBN.MX RBGPF RBGLY RB.L MYMD MRKD.BA MRK.SN MRK.PA MRK.MX MRK MEOBF LLY.MX LLY.DE LLY.BA LLY LILY34.SA IVBXF GXE.DE GLPGF GLPG.AS GLPG GILDD.BA FRPRF CTAGY CTAGF BRM.DE BONS.TA BMYB34.SA BMY.MX BMY.BA BMY BBIXF BBI AZNCF ASZP ABBV34.SA ABBV.MX ABBV.BA ABBV 6MK.DE 4AB.DE 3RB.DE 0Q1G.L 003520.KS HRTX 0J4V.L

Read more →
Published at

Mar 7, 2023 10:58 PM

by stockhead.com.au

positive

positive

As it awaits crucial FDA approval Botanix reckons Aussies have a penchant for backing high-risk companies

Botanix Pharmaceuticals (ASX:BOT) Dr Howie McKibbon believes Aussie Investors are comfortable backing early-stage, high-risk companies.

BOT.AX BBI

Read more →
Published at

Jan 16, 2023 7:00 PM

by globenewswire.com

mixed

mixed

Rhinitis Pipeline Appears Robust With 32+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

The prevalence of rhinitis, both allergic and non-allergic, are on the rise. This has led pharmaceutical companies to develop innovative rhinitis therapies...

SUNPHARMA.NS SUNPHARMA-BL.NS HYL.BR BBI ABVC HLUYY HLUKF

Read more →
Published at

Oct 29, 2022 8:26 AM

by etfdailynews.com

positive

positive

Brickell Biotech (NASDAQ:BBI) & AVROBIO (NASDAQ:AVRO) Financial Comparison

Read Brickell Biotech (NASDAQ:BBI) & AVROBIO (NASDAQ:AVRO) Financial Comparison at ETF Daily News

BBI AVRO AMGXF 4572.T 4563.T

Read more →
Published at

Sep 24, 2022 10:16 AM

by etfdailynews.com

positive

positive

Financial Contrast: Palisade Bio (NASDAQ:PALI) and Brickell Biotech (NASDAQ:BBI)

Read Financial Contrast: Palisade Bio (NASDAQ:PALI) and Brickell Biotech (NASDAQ:BBI) at ETF Daily News

PALI BBI AMGXF 4572.T 4563.T

Read more →
Published at

Sep 1, 2022 7:42 AM

by etfdailynews.com

mixed

mixed

Brickell Biotech (NASDAQ:BBI) vs. Aptose Biosciences (NASDAQ:APTO) Financial Review

Read Brickell Biotech (NASDAQ:BBI) vs. Aptose Biosciences (NASDAQ:APTO) Financial Review at ETF Daily News

BBI APTO APS.TO 4572.T AMGXF 4563.T

Read more →
Published at

Aug 16, 2022 7:18 AM

by etfdailynews.com

positive

positive

Financial Comparison: Quantum Genomics Société Anonyme (OTCMKTS:QNNTF) vs. Brickell Biotech (NASDAQ:BBI)

Read Financial Comparison: Quantum Genomics Société Anonyme (OTCMKTS:QNNTF) vs. Brickell Biotech (NASDAQ:BBI) at ETF Daily News

QNNTF BBI AMGXF ALQGC.PA 4572.T 4563.T 0D1J.L

Read more →
Published at

Aug 14, 2022 8:04 AM

by etfdailynews.com

mixed

mixed

Financial Comparison: Brickell Biotech (NASDAQ:BBI) & Fusion Pharmaceuticals (NASDAQ:FUSN)

Read Financial Comparison: Brickell Biotech (NASDAQ:BBI) & Fusion Pharmaceuticals (NASDAQ:FUSN) at ETF Daily News

FUSN BBI 4572.T AMGXF 4563.T

Read more →
Published at

Aug 11, 2022 10:05 PM

by globenewswire.com

positive

positive

Brickell Biotech Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Phase 1 study of BBI-02 progressing well and expect to initiate MAD part of the study next month On track to report SAD and MAD topline results from...

BXPHF BOT.AX BBI APA.AX

Read more →
Published at

Jul 26, 2022 5:30 PM

by prnewswire.com

mixed

mixed

New Therapeutics Options in Rheumatoid Arthritis Pipeline as 120+ Key Companies are Working on Drug Profiles | DelveInsight

/PRNewswire/ -- DelveInsight's 'Rheumatoid Arthritis Pipeline Insight 2022' report provides comprehensive global coverage of available, marketed, and pipeline...

IDP.DE CPHRF CPH.TO BIIBD.BA BIIBCL.SN BIIB.SN BIIB.MX BIIB.BA BIIB 688177.SS 039200.KQ MYMD LLY.MX LLY.DE LLY.BA LLY LILY34.SA LBPSW LBPS LABP GXE.DE GLPGF GLPG.AS GLPG GILDD.BA FRPRF DDDD.L BBI 0Q1G.L 003520.KS

Read more →
Published at

Jun 22, 2022 10:30 PM

by stockhead.com.au

mixed

mixed

Cast your eyes over these 15 weird and wonderful biotech stocks we found on the ASX

There’s a plethora of biotech stocks on the ASX, so we’ve done the hard work of wading through them for you to find the coolest ones.

RAP.AX ONE.AX MEM.AX LBT.AX BBI AVH.AX ALT.AX PCK.AX OCC.AX HIQ.AX COH.AX ARX.AX VHT.AX MX1.AX MSFT.MI

Read more →
Published at

Jun 16, 2022 8:16 PM

by etfdailynews.com

mixed

mixed

Head-To-Head Analysis: Brickell Biotech (NASDAQ:BBI) vs. BioCryst Pharmaceuticals (NASDAQ:BCRX)

Read Head-To-Head Analysis: Brickell Biotech (NASDAQ:BBI) vs. BioCryst Pharmaceuticals (NASDAQ:BCRX) at ETF Daily News

BCRX.MX BCRX BBI AMGXF 4572.T 4563.T SGIOY SGIOF 4551.T 4507.T 006280.KS

Read more →
Published at

Feb 15, 2022 6:38 PM

by gurufocus.com

positive

positive

Telemetry Investments, L.L.C. Buys PowerShares QQQ Trust Ser 1, Healthwell Acquisition Corp I, iShares Russell 2000 ETF, Sells Healthwell Acquisition Corp I, StoneBridge Acquisition Corp,

GuruFocus Article or News written by GuruFocusNews and the topic is about:

XLNX.MX XLNX XIX.DE X1LN34.SA VRAY SSPKW SSPKU SSPK SPKBU SPKB POND MDLA.MX MDLA IWM.SN HWELU GANX EIGR BBI 0M1U.L

Read more →